Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BRCA2 inhibitors(BRCA2 DNA repair associated inhibitors), RAD51 inhibitors(DNA repair protein RAD51 homolog 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H26ClFN4O5 |
InChIKeyPMUWBFKMLGLUTF-KNUWZQJKSA-N |
CAS Registry2758364-02-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NZ | 01 Jun 2021 |